Literature DB >> 6254574

Ontogenetic development of isoproterenol subsensitivity of myocardial adenylate cyclase and beta-adrenergic receptors in spontaneously hypertensive rats.

R C Bhalla, R V Sharma, S Ramanathan.   

Abstract

[3H]Dihydroalprenolol binding and adenylate cyclase activity in the myocardial membranes of Kyoto Wistar normotensive rats and spontaneously hypertensive rats were compared at various stages of postnatal development ranging from 2 to 36 weeks. Basal as well as agonist-stimulated myocardial adenylate cyclase activity was consistently decreased in spontaneously hypertensive rats as compared to normotensive rats as early as 2 weeks of age with significant differences (P < 0.05) observed after 6 weeks of age. When results were expressed as percent stimulation over the basal activity, only isoproterenol plus GTP-stimulated enzyme activity was reduced by 25--30% in spontaneously hypertensive rats, suggesting a specific loss of stimulation by isoproterenol in hypertensive animals. The number of [3H]dihydroalprenolol binding sites of KD for dihydroalprenolol binding were comparable between spontaneously hypertensive and normotensive rats at 3, 6 and 12 weeks of age. The competition of isoproterenol with [3H]dihydroalprenolol for the specific binding sites showed that the affinity of isoproterenol binding was decreased 3--4-fold in spontaneously hypertensive compared with normotensive rats. With postnatal development in age, basal as well as agonist-stimulated activities decreased progressively in both spontaneously hypertensive and normotensive rats. Similarly, the number of [3H]dihydroalprenolol binding sites decreased with the development in age, whereas affinity of dihydroalprenolol binding increased up to 12 weeks of age. These results therefore suggest that adenylate cyclase activity and the number of beta-adrenergic receptors in rat heart, decrease with age and that in hypertension, specific decrease in isoproterenol stimulation of cyclase appears at all stages of development.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254574     DOI: 10.1016/0304-4165(80)90326-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Low sodium diet corrects the defect in lymphocyte beta-adrenergic responsiveness in hypertensive subjects.

Authors:  R D Feldman; W J Lawton; W L McArdle
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

2.  Beta-adrenergic receptor characteristics of postnatal rat myocardial cell preparations.

Authors:  A A Welder; T Machu; S W Leslie; R E Wilcox; J Bradlaw; D Acosta
Journal:  In Vitro Cell Dev Biol       Date:  1988-08

3.  Leukocyte beta-receptor alterations in hypertensive subjects.

Authors:  R D Feldman; L E Limbird; J Nadeau; D Robertson; A J Wood
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

4.  Properties of cardiac alpha- and beta-adrenoceptors in spontaneously hypertensive rats.

Authors:  M Böhm; D Beuckelmann; F Diet; G Feiler; M J Lohse; E Erdmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

5.  Age-associated decrease in histamine-induced vasodilation may be due to reduction of cyclic GMP formation.

Authors:  H Moritoki; A Tanioka; Y Maeshiba; T Iwamoto; Y Ishida; H Araki
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

6.  Reduced cAMP levels and glycogen phosphorylase activation in isoproterenol perfused SHR myocardium.

Authors:  R V Sharma; R C Gupta; M Ramanadham; R C Venema; R C Bhalla
Journal:  Basic Res Cardiol       Date:  1983 Nov-Dec       Impact factor: 17.165

7.  Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats. Relationship to adenylate cyclase inhibition.

Authors:  M B Anand-Srivastava
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

8.  Modulation of Gi Proteins in Hypertension: Role of Angiotensin II and Oxidative Stress.

Authors:  Madhu B Anand-Srivastava
Journal:  Curr Cardiol Rev       Date:  2010-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.